Heartseed Inc.

219A

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-14FY2026 Q2

Revenue

4.7100M JPY

YoY -75.6%

Operating Income

-6.2100M JPY

YoY -169.4%

Net Income

-5.5100M JPY

YoY -178.4%

EPS

-24.2JPY

YoY -176.6%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

30.3億円

20.1億円

9.9億円

-22.5百万円

-10.4億円

Rev: 8.7億円Op: -10.4億円NI: -8.1億円

Rev: 30.3億円Op: 2.7億円NI: 1.9億円

2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress4.700M

Revenue Forecast4.700M

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan